Alto Neuroscience Inc

ANRONYSE · USD
24.91USD-2.21 (-8.15%)
2510

Alto Neuroscience Inc (ANRO) Option Chain

Read more

Tracking the ANRO option chain helps you see every strike and expiry on Alto Neuroscience Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ANRO options activity at a glance. Use our scanner to monitor the ANRO option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ANRO stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where ANRO options are being actively traded, and where they are not.

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the treatment of patients with major depressive disorder (MDD) and post-traumatic stress disorder; ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties to treat patients with MDD; and ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor for the treatment of cognitive impairment associated with schizophrenia. It also develops ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist to treat patients with MDD and higher levels of anhedonia, and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor for the treatment of MDD.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.00005.097.4110.5014.5017.50-40.76—4.900.004.9004100.00
0.16005.094.918.0012.0020.00-32.30—4.900.004.90010199.84
2.1014005.092.415.509.5022.50-23.83—4.900.004.90016997.90
11.0523805.250.003.507.0025.00-15.37—4.900.094.810488.95
57.06004.900.00—4.9030.00+1.56—4.905.09-0.190042.94

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank19.44% Low
  • Market cap (M$)1,088
  • 52 weeks high-27.64%
  • 52 weeks low116.79%
  • Analyst recommendationStrong Buy
    1.27
  • Target price$38.88
    56.08% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-10
  • P/E—
  • Future P/E—
  • EPS (ttm)-2.49
  • EPS growth next 5 years-9.01%

As of Nov 16, 2026